SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0000905718-17-000484
Filing Date
2017-04-21
Accepted
2017-04-21 16:01:27
Documents
2
Period of Report
2017-04-03

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT ende_fm3apr32017.html 3  
1 OWNERSHIP DOCUMENT ende_fm3apr32017.xml 3 1580
2 EX-24 ende_poa.htm EX-24 5789
  Complete submission text file 0000905718-17-000484.txt   8803
Mailing Address C/O MATINAS BIOPHARMA HOLDINGS, INC. 1545 ROUTE 206 SOUTH, SUITE 302 BEDMINSTER NJ 07921
Business Address
Ende Eric J (Reporting) CIK: 0001494386 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-38022 | Film No.: 17775590

Mailing Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921
Business Address 1545 ROUTE 206 SOUTH SUITE 302 BEDMINSTER NJ 07921 908-443-1860
Matinas BioPharma Holdings, Inc. (Issuer) CIK: 0001582554 (see all company filings)

IRS No.: 463011414 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations